Aramark
56.91USD
-0.6700 (-1.16%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.75▼ | $0.76 | 2 | 7 |
| Next quarter | $0.64▲ | $0.62 | 8 | 1 |
| Current year | $2.28▲ | $2.25 | 13 | 1 |
| Next year | $2.8▲ | $2.69 | 14 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.48 | $0.52 | +0.04 (+7.2%) |
| 2026-03-31 | $0.48 | $0.49 | +0.01 (+2.7%) |
| 2025-12-31 | $0.51 | $0.51 | +0.00 (+0.3%) |
| 2025-09-30 | $0.65 | $0.57 | -0.08 (-12.7%) |
190 ratings from 22 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $60 $70 | Aug 19, 2026 |
| Citigroup | Maintained | Buy | $70.5 $74 | Aug 13, 2026 |
| JP Morgan | Maintained | Overweight | $55 $70 | Aug 13, 2026 |
| Stifel | Maintained | Buy | $54 $70 | Aug 12, 2026 |
| Jefferies | Maintained | Buy | $62 $70 | Aug 12, 2026 |
| UBS | Maintained | Buy | $67 $71 | Aug 12, 2026 |
| Baird | Maintained | Outperform | $63 $69 | Aug 12, 2026 |
| Truist Securities | Maintained | Buy | $58 $70 | Jul 27, 2026 |
| Oppenheimer | Maintained | Outperform | $60 $65 | Jun 29, 2026 |
| Citigroup | Maintained | Buy | $63 $70.5 | Jun 22, 2026 |
| Oppenheimer | Maintained | Outperform | $50 $60 | Jun 11, 2026 |
| B of A Securities | Maintained | Buy | $59 $62 | Jun 2, 2026 |
| B of A Securities | Maintained | Buy | $54 $59 | May 19, 2026 |
| RBC Capital | Maintained | Outperform | $47 $55 | May 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $45 $50 | May 13, 2026 |
| JP Morgan | Maintained | Overweight | $49 $55 | May 13, 2026 |
| Truist Securities | Maintained | Buy | $50 $58 | May 13, 2026 |
| UBS | Maintained | Buy | $48 $56 | May 13, 2026 |
| Stifel | Maintained | Buy | $47 $54 | May 13, 2026 |
| Baird | Maintained | Outperform | $50 $58 | May 13, 2026 |
| UBS | Maintained | Buy | $47 $48 | Apr 8, 2026 |
| Oppenheimer | Maintained | Outperform | $43 $50 | Mar 25, 2026 |
| Truist Securities | Maintained | Buy | $46 $50 | Feb 17, 2026 |
| Citigroup | Maintained | Buy | $49 $51 | Feb 12, 2026 |
| Stifel | Maintained | Buy | $44 $47 | Feb 11, 2026 |
156 filings from 17 insiders · 24 buy / 2 sell over 6m
Officers and directors of ARMK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Tarangelo James J.Officer, EVP and CFO | ExerciseStock Option (Right to Buy) | 8.9k | — | — | Sep 3, 2026 |
| Tarangelo James J.Officer, EVP and CFO | Tax | 6.0k | $56.81 | $344k | Sep 3, 2026 |
| Tarangelo James J.Officer, EVP and CFO | Exercise | 8.9k | $24.58 | $218k | Sep 3, 2026 |
| BRUNO MARC AOfficer | Sell | 70.6k | $60.92 | $4.31M | Aug 13, 2026 |
| BRUNO MARC AOfficer | Exercise | 210.4k | $24.58 | $5.59M | Aug 13, 2026 |
| CREED GREGDirector | Grant | 583 | — | — | Jul 10, 2026 |
| DREILING RICHARD WDirector | Grant | 475 | — | — | Jul 10, 2026 |
| KEVERIAN KENNETH MDirector | Grant | 65 | — | — | Jun 3, 2026 |
| TARANGELO JAMES JChief Financial Officer | Grant | 65 | — | — | Jun 3, 2026 |
| BRUNO MARC AOfficer | Grant | 299 | — | — | Jun 3, 2026 |
| LOPEZ-GARCIA PATRICIA EDirector | Grant | 65 | — | — | Jun 3, 2026 |
| CREED GREGDirector | Grant | 150 | — | — | Jun 3, 2026 |
| CAMERON SUSAN MDirector | Grant | 108 | — | — | Jun 3, 2026 |
| WILLS KEVIN GDirector | Grant | 36 | — | — | Jun 3, 2026 |
| ZILLMER JOHN JChief Executive Officer | Grant | 973 | — | — | Jun 3, 2026 |
| SADOVE STEPHEN IDirector | Grant | 199 | — | — | Jun 3, 2026 |
| HELLER BRIDGETTE PDirector | Grant | 80 | — | — | Jun 3, 2026 |
| DREILING RICHARD WDirector | Grant | 32 | — | — | Jun 3, 2026 |
| HARRINGTON LAUREN ANNEGeneral Counsel | Grant | 110 | — | — | Jun 3, 2026 |
| DELGHIACCIO BRIAN MDirector | Grant | 36 | — | — | Jun 3, 2026 |
No analyst notes on ARMK yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 11 | 1 | 0 | 1 | Buy2.06 |
| 1 mo ago | 3 | 11 | 1 | 1 | 0 | Buy2.00 |
| 2 mo ago | 3 | 11 | 1 | 1 | 0 | Buy2.00 |